Stocks To Watch

Axis Bank: Specified Undertaking of the Unit Trust of India to sell 1.95% of the bank's equity through an Offer for Sale. The initial plan is for the sale of 3.60 crore shares or 1.21% of the total equity with a greenshoe option to sell another 2.20 crore shares or 0.74% of the total equity. The floor price of Rs 680 per share is at a 4.48% discount to Tuesday's closing price. The OFS opens for non-retail investors today and for retail investors tomorrow.

JSW Energy: The wholly-owned subsidiary of the company, JSW Hydro Energy, has raised $707 million by allotment of dollar-denominated senior secured notes.

Infosys, Majesco: Announced strategic collaboration to help joint customers accelerate their digital transformation journey, enabling them to unlock new opportunities, address the demand for personalised customer experiences, operational effectiveness, and digital adoption across the insurance business value chain.

Canara Bank: Confident of Rs 15,000 crore recovery this year, said CEO Lingam Prabhakar during a conference call.

Kirloskar Oil Engines: Suspended operations at main Kagal Plant, Kagal Plant-II and KMW Kagal Plant-III in Kolhapur to comply with District Collector's covid order. The plants will remain shut between May 18-23.

World Markets

Dow - 267
Nasdaq - 75
Dax - 10
Nikkei - 270
Hangseng Closed
Sgxnifty - 62 (15089)
Brent Crude 68.19
Dow Fut - 45
Dollar Index 89.78

Hester Biosciences partners with Gujarat Government & OmniBRx for manufacturing COVID vaccine https://www.dsij.in/DSIJArticleDetail/ArtMID/10163/ArticleID/18345/Hester-Biosciences-partners-with-Gujarat-Government-OmniBRx-for-manufacturing-COVID-vaccine#.YKK0e3vwrfU.whatsapp

Kolte Patil zooms nearly 2 per cent on securing two new projects in Pune https://www.dsij.in/DSIJArticleDetail/ArtMID/10163/ArticleID/18350/Kolte-Patil-zooms-nearly-2-per-cent-on-securing-two-new-projects-in-Pune#.YKK0PTnWWv4.whatsapp

Aarti Ind
- Announces 1:1 Bonus for shareholders

- Also announces 3/sh Dividend (1.5 Ex-Bonus)

- Will also raise 1500 Cr via QIP and issue of Warrants!

Sources to CNBC Awaaz

*SUUTI likely to sell stake in Axis Bank*

*SUUTI likely to sell nearly 4 crores shares in Axis Bank*

*SUTTI likely to sell stake via OFS route, awaiting board approval*

SUUTI plans to sell stake in Axis Bank Worth Rs 2500-3000 crore

Bankers approach funds for interest in OFS

*Alert: SUUTI holds 3.45% stake in Axis Bank as of 31st March*

*Ester Industries Ltd.* | *CMP* Rs. 151 | *M Cap* Rs. 1259 Cr | *52 W H/L* 159/27
(Nirmal Bang Retail Research)
*Result is ok*
Revenue from Operations came at Rs. 297 Cr (16.2% QoQ, 17% YoY) vs QoQ Rs. 255.7 Cr, YoY Rs. 253.9 Cr
EBIDTA came at Rs. 58.8 Cr (6.4% QoQ, 15.6% YoY) vs QoQ Rs. 55.2 Cr, YoY Rs. 50.8 Cr
EBITDA Margin came at 19.8% vs QoQ 21.6%, YoY 20%
Adj. PAT came at Rs. 33.9 Cr vs QoQ Rs. 32.9 Cr, YoY Rs. 36.9 Cr
Quarter EPS is Rs. 4.1
Share is trading at P/E of 8.9x TTM EPS

*Jindal Stainless (Hisar) Ltd.* | *CMP* Rs. 180 | *M Cap* Rs. 4247 Cr | *52 W H/L* 193/37
(Nirmal Bang Retail Research)
*Result improved*
Revenue from Operations came at Rs. 2758.5 Cr (-2.2% QoQ, 35.9% YoY) vs QoQ Rs. 2822 Cr, YoY Rs. 2030.3 Cr
EBIDTA came at Rs. 364.1 Cr (3.8% QoQ, 109.6% YoY) vs QoQ Rs. 350.7 Cr, YoY Rs. 173.7 Cr
EBITDA Margin came at 13.2% vs QoQ 12.4%, YoY 8.6%
Adj. PAT came at Rs. 209.5 Cr vs QoQ Rs. 182.1 Cr, YoY Rs. 99.2 Cr
Quarter EPS is Rs. 8.9
Share is trading at EV/EBITDA of 6.2x Trailing EBITDA

*PI Industries Ltd.* | *CMP* Rs. 2709 | *M Cap* Rs. 41101 Cr | *52 W H/L* 2734/1426
(Nirmal Bang Retail Research)
*Result below expectation*
Revenue from Operations came at Rs. 1197.1 Cr (3% QoQ, 40% YoY) vs expectation of Rs. 1120.7 Cr, QoQ Rs. 1162.1 Cr, YoY Rs. 855.2 Cr
EBIDTA came at Rs. 227.3 Cr (-17.5% QoQ, 22% YoY) vs expectation of Rs. 254.8 Cr, QoQ Rs. 275.5 Cr, YoY Rs. 186.3 Cr
EBITDA Margin came at 19% vs expectation of 22.7%, QoQ 23.7%, YoY 21.8%
Adj. PAT came at Rs. 179.8 Cr vs expectation of Rs. 188.8 Cr, QoQ Rs. 195.4 Cr, YoY Rs. 110.7 Cr
Quarter EPS is Rs. 11.9
Share is trading at P/E of 44.8x FY22E EPS

*Ujjivan Small Finance Bank Ltd.* | *CMP* Rs. 31 | *M Cap* Rs. 5289 Cr | *52 W H/L* 45/25
(Nirmal Bang Retail Research)
*Result continued to remain weak*
Net Interest Income came at Rs. 368.1 Cr vs YoY Rs. 466.6 Cr, QoQ Rs. 432.3 Cr
Non Interest Income came at Rs. 117.3 Cr vs YoY Rs. 72.2 Cr, QoQ Rs. 100.4 Cr
PBP came at Rs. 158.7 Cr vs YoY Rs. 190.6 Cr, QoQ Rs. 203.8 Cr
Provisions came at Rs. -25.2 Cr vs YoY Rs. 96.9 Cr, QoQ Rs. 583.5 Cr
Co is carrying Rs. 172 Cr of contingent provisions (1.2%)
Adj. PAT came at Rs. 136.5 Cr vs YoY Rs. 73.1 Cr, QoQ Rs. -278.8 Cr
Gross NPA came at Rs. 1070.6 Cr vs QoQ Rs. 658.7 Cr at 7.07% vs QoQ 4.83%
Net NPA came at Rs. 424.6 Cr vs QoQ Rs. 279.6 Cr at 2.93% vs QoQ 2.05%
PAR>0 book stood at 15.0% against QoQ 16.2% . Improvement seems weak considering economic activity was very strong in Q4FY21. With the second wave, Q1FY22 performance is likely to get impacted.
PAR 0-90 book constitutes 7.9%
Quarter EPS is Rs. 0.8
Share is trading at P/E 12.1x FY22E EPS and trailing P/Adj BV of 2.1x

*Gujarat Alkalies & Chemicals Ltd.* | *CMP* Rs. 433 | *M Cap* Rs. 3180 Cr | *52 W H/L* 469/302
(Nirmal Bang Retail Research)
*Result has improved*
Revenue from Operations came at Rs. 671.4 Cr (3.3% QoQ, 8% YoY) vs QoQ Rs. 650.2 Cr, YoY Rs. 621.6 Cr
EBIDTA came at Rs. 96.5 Cr (22.7% QoQ, 20.8% YoY) vs QoQ Rs. 78.6 Cr, YoY Rs. 79.9 Cr
EBITDA Margin came at 14.4% vs QoQ 12.1%, YoY 12.8%
Adj. PAT came at Rs. 34.7 Cr vs QoQ Rs. 33.2 Cr, YoY Rs. 11.4 Cr
Lower PAT growth as compared to EBITDA QoQ is on account of lower other Income.
Quarter EPS is Rs. 4.7
Share is trading at P/E of 19.2x TTM EPS

*Glaxosmithkline Pharmaceuticals Ltd.* | *CMP* Rs. 1516 | *M Cap* Rs. 25677 Cr | *52 W H/L* 1808/1190
(Nirmal Bang Retail Research)
*Result is in-line with expectations*
Revenue from Operations came at Rs. 813.8 Cr (-5.1% QoQ, 4.9% YoY) vs expectation of Rs. 818.1 Cr, QoQ Rs. 857.2 Cr, YoY Rs. 775.8 Cr
EBIDTA came at Rs. 170.9 Cr (-16.8% QoQ, -1.5% YoY) vs expectation of Rs. 172.9 Cr, QoQ Rs. 205.5 Cr, YoY Rs. 173.6 Cr
EBITDA Margin came at 21% vs expectation of 21.1%, QoQ 24%, YoY 22.4%
Adj. PAT came at Rs. 133.3 Cr vs expectation of Rs. 126.4 Cr, QoQ Rs. 146 Cr, YoY Rs. 126.8 Cr
Quarter EPS is Rs. 7.9
Share is trading at P/E of 39.7x FY22E EPS

*Aarti Industries Ltd.* | *CMP* Rs. 1746 | *M Cap* Rs. 30421 Cr | *52 W H/L* 1815/850
(Nirmal Bang Retail Research)
*Result is marginally below expectations*

*Gross Margin remain Stable QoQ, higher other expenses led to decline in EBITDA margin*
Revenue from Operations came at Rs. 1209.4 Cr (1.9% QoQ, 12.4% YoY) vs expectation of Rs. 1247.8 Cr, QoQ Rs. 1186.8 Cr, YoY Rs. 1076.2 Cr
EBIDTA came at Rs. 260.3 Cr (-8.7% QoQ, 18.9% YoY) vs expectation of Rs. 296.5 Cr, QoQ Rs. 285 Cr, YoY Rs. 218.9 Cr
EBITDA Margin came at 21.5% vs expectation of 23.8%, QoQ 24%, YoY 20.3%
Adj. PAT came at Rs. 139.3 Cr vs expectation of Rs. 178.7 Cr, QoQ Rs. 165.3 Cr, YoY Rs. 110.4 Cr
Quarter EPS is Rs. 8
Share is trading at P/E of 43.4x FY22E EPS

Route Mobile Concall Update
*Outlook – Positive*
Management guides for a revenue growth of 20% organically in FY22. Volume growth would be 10-15%. Focus would be majority towards improving gross margin . Q4FY21 gross margin improved to 22% vs 18% QoQ owing passing on DLT charges to customers which had taken a hit last quarter. Gross margin of 22% is sustainable . With change in product mix management aspires to reach gross margin of 25%.
Share is trading at P/E of 54x FY22E EPS

*Minda Corporation Ltd.* | *CMP* Rs. 111 | *M Cap* Rs. 2642 Cr | *52 W H/L* 114/54
(Nirmal Bang Retail Research)
*Result is above expectations*
Revenue from Operations came at Rs. 794.1 Cr (7.3% QoQ, 13.8% YoY) vs expectation of Rs. 740.7 Cr, QoQ Rs. 739.8 Cr, YoY Rs. 697.9 Cr
Gross Profit Margins came at 36.8% vs QoQ 37.3%, YoY 39.2%
EBIDTA came at Rs. 89 Cr (8.8% QoQ, 131.1% YoY) vs expectation of Rs. 79.2 Cr, QoQ Rs. 81.8 Cr, YoY Rs. 38.5 Cr
EBITDA Margin came at 11.2% vs expectation of 10.7%, QoQ 11.1%, YoY 5.5%
Adj. PAT came at Rs. 54.6 Cr vs expectation of Rs. 45.2 Cr, QoQ Rs. 49.5 Cr, YoY Rs. -6.5 Cr
Quarter EPS is Rs. 2.3
Share is trading at P/E of 14.7x FY22E EPS

*Torrent Pharmaceuticals Ltd.* | *CMP* Rs. 2731 | *M Cap* Rs. 46215 Cr | *52 W H/L* 3040/2232
(Nirmal Bang Retail Research)
*Result is in-line with expectations*
Revenue from Operations came at Rs. 1937 Cr (-2.9% QoQ, -0.5% YoY) vs expectation of Rs. 1996.8 Cr, QoQ Rs. 1995 Cr, YoY Rs. 1946 Cr
EBIDTA came at Rs. 582 Cr (-4.1% QoQ, 6.2% YoY) vs expectation of Rs. 586.1 Cr, QoQ Rs. 607 Cr, YoY Rs. 548 Cr
EBITDA Margin came at 30% vs expectation of 29.4%, QoQ 30.4%, YoY 28.2%
Adj. PAT came at Rs. 324 Cr vs expectation of Rs. 273.1 Cr, QoQ Rs. 297 Cr, YoY Rs. 314 Cr
Quarter EPS is Rs. 19.1
Share is trading at P/E of 33.3x FY22E EPS

Super Duper Techno Funda Mid Term Call

Buy Agarind at CMP of 205 - 206 and dips till 195
Sl 187
Targets:- 210 - 213 - 216 - 219 - 222 - 226 - 230+
Above 230 we can see 240 - 255 +

Disclaimer:- I am not SEBI Registered.please consult your financial advisor before investing

BSE - 531921
NSE - 3389

Shbclq 102❤️❤️

PGIL 199.95 ❤️

Pioneer Embroideries 57 ❤️

All targets done ✅✅

Booked 70% qty